NCT03943095View on ClinicalTrials.gov

Study to Characterize the Efficacy of a Dual Active Dentifrice for the Relief of Dentin Hypersensitivity

PHASE2CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

May 13, 2019

Primary Completion Date

August 28, 2019

Study Completion Date

August 28, 2019

Conditions
Dentin HypersensitivityDentin Sensitivity
Interventions
OTHER

Potassium Nitrate

The test dentifrice contains 5% w/w potassium nitrate.

OTHER

Stannous Fluoride

The test and control dentifrices contain 0.454% w/w stannous fluoride (1100 ppm fluoride).

Trial Locations (1)

L5N 6J2

GSK Investigational Site, Mississauga

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY